President Donald Trump is to hold talks on Tuesday with Russian President Vladimir Putin as he looks to get buy-in on a U.S. ceasefire proposal he hopes can create a pathway to ending Russia’s ...
Life’s passion: Peggy Montes, 88, carries a passion for empowering women and educating children through the museum she founded.
President Donald Trump announced he will release 80,000 pages of unredacted files Tuesday about the assassination of President John F. Kennedy, after promising on the campaign trail to declassify ...
LightPath Technologies, Inc. ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced its ...
About Alto Ingredients, Inc. Alto Ingredients, Inc. (NASDAQ: ALTO) is a leading producer and distributor of specialty alcohols, renewable fuels and essential ingredients. Leveraging the unique ...
Trump Media and Technology Group Corp. (Nasdaq: DJT) ("TMTG" or the "Company"), operator of the social media platform Truth Social, the streaming platform ...
50m
Irish Star on MSNTexas bill prohibits students from exhibiting “non-human behaviors” like meowing and barkingA new bill introduced in the Texas legislature aims to ban “non-human” behaviors in public schools, often exhibited by ...
AccuStem pursuing strategic commercialization plan intending to launch the MSC test in the US in 2026 LONDON and PHOENIX, Ariz., March 18, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT ...
By Mzoxolo MpolaseFor three decades, South Africa has been treated as a political anomaly—a state where governance failures have been dismissed as unfortunate by-products of history rather than ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, ...
Dogwood Therapeutics, Inc. (Nasdaq: DWTX) ("Dogwood” or the "Company”), a development-stage biopharmaceutical company focused on advancing first-in-class, non-opioid, treatments for chronic and acute ...
Under the terms of the Sixth Amendment, Liquidia will receive $25.0 million at closing with the potential to receive two additional tranches of funding: $50.0 million upon the first commercial sale of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results